leave for medical reasons. Its shares rose after hours.
The following are immediate comments from investors and analysts:
ASHOK KUMAR, ANALYST, RODMAN & RENSHAW
"The only place where we saw some upside surprise was with iPad."
"It was very strong in near-term product momentum. For the 12-month horizon the operational risk is very limited because most of its new products will be upgrades."
"The unknown is what happens beyond this timeframe. Steve (Jobs) is the conductor so to speak. Yes, there's a deep bench at Apple but, it's only Steve that makes it bigger than the sum of its parts."
"You've very big egos at Apple. Steve is unique in that he can corral all these forces. I don't think there's another individual at Apple capable of that."
"For investors, the options are stark near term. There's no comparable company in the tech sector which is considered an alternative to Apple."
"You can't put it into IBM. IBM is a different beast. It's more of a beta story rather than an alpha story. It's not going to outperform. The lack of alternatives will keep investors in Apple."
RAJESH GHAI, ANALYST, THINKEQUITY
"As far as execution is concerned (chief operating officer) Tim Cook has been the guy leading the effort over there. He's in charge and I think they have pretty decent bench strength to help him execute on the plan."
"Longer term, Job's creativity and vision are going to be important and we'll have to see if anyone else can step up and provide that vision as far as products are concerned. But the stock really depends on what the company is going to do for the
next couple of years and I don't see any problem on that account."
DANIEL ERNST, ANALYST, HUDSON SQUARE RESEARCH
"In some ways it was no surprise. Apple blew away earnings expectations, again. It seems to be a recurring event for these guys. It was across the board, top to bottom another great quarter."
"It is still impressive even for someone who watches it day to day to see an outperformance of this magnitude."
On Jobs' health: "The good news is I feel like the company has been a little more straightforward this time around. As we said last time around, the depth of product engineering and design and capacity of the company is not the result of one guy. It's the result of a team. I think the DNA of Steve Jobs' design and business acumen is deeply ingrained in the company. It's my opinion, Apple no longer needs Steve Jobs -- that is part of the company's success."
YAIR REINER, ANALYST, OPPENHEIMER & CO
"Just another blowout. Apple blew out expectations in the product lines where you might think they would: the iPhone and the iPad."
"Analysts like me keep on raising expectations and Apple somehow manages to exceed them time after time."
"The results came in well ahead of rising street estimates, and Apple's guidance, which is typically very conservative and undershoots Wall Street estimates, this time leaped slightly ahead. That's a rare occurrence."
"I think Apple has been extremely consistent in the conservatism of its forecast. I don't think that Steve Jobs' medical leave would alter that. The strong guidance is probably more indicative of Apple's confidence on the eve of the iPhone's launch with Verizon."
"Whether Steve Jobs stays or goes, the impact from that probably won't be felt in the company's results for two or three years. That leaves a large interim period during which investors will have no choice but to focus on the information that they have and that's going to be the results and the products that Apple actually comes out with."
VAN BAKER, ANALYST, GARTNER
"Looks pretty impressive. The 86 percent increase for iPhones, that is confounding. It's not like the market is not relatively mature."
"Hard to criticize anything in here. I will be curious to get a little more detail on the iPods."
Disclaimer: All information on this news has been compiled from their respective official websites or through public domain sites and leading newspapers. Although, we have taken reasonable efforts to provide you with accurate information, but we assumes no responsibility for the accuracy (or inaccuracy) of the Information and would advise you to verify it from the official product provider. We cannot guarantee that the information on this page is 100% correct. If you would like to advertise on our site please contact us
No comments:
Post a Comment